PCSK9과 LDL-C: 운동의 역할

키워드

참고문헌 (34)

1. Goldstein JL, "The LDL receptor", Arterioscler Thromb Vasc Biol, 29(4), pp.431~438 (2009)
2. Baigent C, "Efficacy and safety of cholesterol-lowering treatment : prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins", Lancet, 366(9493), pp.1267~1278 (2005)
3. Lewington S, "Blood cholesterol and vascular mortality by age, sex, and blood pressure : a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths", Lancet, 370(9602), pp.1829~1839 (2007)
4. Preiss D, "Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy : a meta-analysis", Jama, 305(24), pp.2556~2564 (2011)
5. Carter AA, "Risk of incident diabetes among patients treated with statins: population based study", BMJ, 346, pp.f2610~ (2013)
6. Abifadel M, "Mutations in PCSK9 cause autosomal dominant hypercholesterolemia", Nat Genet, 34(2), pp.154~ (2003)
7. Poirier S, "The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor(LDLR)and its closest family members VLDLR and ApoER2", J Biol Chem, 283(4), pp.2363~2372 (2008)
8. Denis M, "Gene inactivation of proprotein convertase subtilisin", kexin type 9 reduces atherosclerosis in mice, 2012, pp.125(7), 894~901
9. Burke AC, "PCSK9: Regulation and target for drug development for dyslipidemia", Annu Rev Pharmacol Toxicol, 5, pp.223~244 (2017)
10. Guo YL, "PCSK9 and lipid lowering drugs", Clin Chim Acta, 437, pp.66~71 (2014)
11. Stein EA, "Effect of a monoclonal antibody to PCSK9 on LDL cholesterol", N Engl J Med, 366(12), pp.1108~1118 (2012)
12. McKenney JM, "Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin", kexin type 9 serine protease, SAR236553, J Am Coll Cardiol, pp.2012, 59(25)[DOI]
13. Li W, "Aerobic exercise training inhibits neointimal formation via reduction of PCSK9 and LOX-1 in atherosclerosis", Biomedicines, 8(4), pp.92~ (2020)
14. Saely CH, "Impact of diet and exercise on proprotein convertase subtilisin", kexin 9 : a mini-review, 2016, pp.87, 10~13
15. Wang Y, "Effects of aerobic exercise on lipids and lipoproteins", Lipids Health Dis, 16(1), pp.132~ (2017)
16. Kosenko T, "Low density lipoprotein binds to proprotein convertase subtilisin", kexin type-9(PCSK9)in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation, 2013, pp.288(12), 8279~8288
17. Cohen JC, "Sequence variations in PCSK9, low LDL, and protection against coronary heart disease", N Engl J Med, 354(12), pp.1264~1272 (2006)
18. Seidah NG, "The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation", Proc Natl Acad Sci U S A, 100(3), pp.928~933 (2003)
19. Qian Y-W, "Secreted PCSK9downregulates low density lipoprotein receptor through receptor-mediated endocytosis", J lipid Res, 48(7), pp.1488~1498 (2007)
20. Urban D, "Targeting the proprotein convertase subtilisin", kexin type 9 for the treatment of dyslipidemia and atherosclerosis, 2013, pp.62(16), 1401~1408
21. Abifadel M, "A PCSK9variant and familial combined hyperlipidaemia", J Med Genet, 45(12), pp.780~786 (2008)
22. Arsenault BJ, "PCSK9 levels in abdominally obese men : association with cardiometabolic risk profile and effects of a one-year lifestyle modification program", Atherosclerosis, 236(2), pp.321~326 (2014)
23. Kamani CH, "Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population", Eur J Clin Invest, 45(10), pp.1017~1024 (2015)
24. Farahnak Z, "Exercise training increased gene expression of LDL-R and PCSK9 in intestine : link to transintestinal cholesterol excretion", Gen Physiol Biophys, 37(3), pp.309~317 (2018)
25. Sock ETN, "Combined effects of rosuvastatin and exercise on gene expression of key molecules involved in cholesterol metabolism in ovariectomized rats", PLos One, 11(7), pp.e0159550~ (2016)
26. Wen S, "Treadmill exercise training modulates hepatic cholesterol metabolism and circulating PCSK9Concentration in High-Fat-Fed Mice", J lipids, 2013, pp.908048~ (2013)
27. Pinto PR, "Aerobic exercise training enhances the in vivo cholesterol trafficking from macrophages to the liver independently of changes in the expression of genes involved in lipid flux in macrophages and aorta", Lipids Health Dis, 14, pp.109~ (2015)
28. Boyer M, "Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease", J Clin Lipidol, 10(6), pp.1353~1361 (2016)
29. Sponder M, "Effect of long-term physical activity on PCSK9, high- and low-density lipoprotein cholesterol, and lipoprotein(a) levels: a prospective observational trial", Pol Arch Intern Med, 127(7-8), pp.506~511 (2017)
30. Sock ETN, "LDL Receptor and Pcsk9 transcripts are decreased in liver of ovariectomized rats : eff ects of exercise training", Horm Metab Res, 46(8), pp.550~555 (2014)
31. Leren TP, "Mutations in the PCSK9 gene in norwegian subjects with autosomal dominant hypercholesterolemia", Clin Genet, 65(5), pp.419~422 (2004)
32. Gu HM, "Hypercholesterolemia, low density lipoprotein receptor and proprotein convertase subtilisin", kexin-type 9, 2015, pp.29(5), 356~361
33. Ferri N, "Proprotein convertase subtilisin kexin type 9(PCSK9)secreted by cultured smooth muscle cells reduces macrophages LDLR levels", Atherosclerosis, 220(2), pp.381~386 (2012)
34. Mäkelä KA, "Effect of physical activity on plasma PCSK9 in subjects with high risk for type 2 diabetes. Front Physiol. 2019;10:456. type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation", J Biol Chem, 288(12), pp.8279~8288 (2013)

관련 논문AI추천